The e-posters will be available for browsing at the AACR virtual meeting platform beginning at 12:00 PM PT on April 17, as well as on the OBI Pharma website ( beginning on April 18. 1 AACR Annual ...
Pharmaceutical Technology on MSN
Adcendo secures $75m in Series C funding for ADC development
Funding will enable progress on the ADCE-T02 Phase I Tiffany-01 cohort expansion in a range of solid tumours.
Trastuzumab pamirtecan, being developed under a 2023 partnership between BioNTech and DualityBio, elicited a 44.1% overall ...
Gilead’s third acquisition since late February hands it a technology designed to make antibody-drug conjugates less toxic and ...
Day One Biopharmaceuticals, now a commercial-stage company after landing FDA approval of its first drug two months ago, is building up its pipeline with a deal that gives it rights to a novel drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results